Indian Journal of Endocrinology and Metabolism

REVIEW ARTICLE
Year
: 2020  |  Volume : 24  |  Issue : 3  |  Page : 237--243

Trabecular bone score—An emerging tool in the management of osteoporosis


Remya Rajan, Kripa E Cherian, Nitin Kapoor, Thomas V Paul 
 Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India

Correspondence Address:
Thomas V Paul
Department of Endocrinology, Diabetes & Metabolism, Christian Medical College, Vellore, Tamil Nadu
India

Areal bone mineral density (aBMD) is currently the gold standard for the diagnosis of osteoporosis, however, it has its own pitfalls. Trabecular bone score (TBS), a novel tool in the evaluation of osteoporosis is an indirect indicator of bone microarchitecture. It is a textural index that evaluates pixel gray-level variations in the lumbar spine DXA (dual energy X-ray absorptiometry) image. Both cross-sectional and longitudinal studies have demonstrated that TBS may independently predict fragility fractures. TBS can also be used to adjust FRAX probabilities of fracture, though data available till date doesn't support any additional benefit. TBS also shows an improving trend with anti-osteoporotic treatment; however, the least significant change (LSC) is high that it takes more than 2 years for the change to manifest. TBS is also used in the evaluation of bone strength in cases of secondary osteoporosis. Though TBS predicts fracture risk independently in both genders, with the currently available data, it cannot be recommended as a standalone tool for decision regarding treatment of osteoporosis. TBS can be used as a tool to complement BMD in assessment of bone health. Additional studies are needed to assess its utility in clinical practice.


How to cite this article:
Rajan R, Cherian KE, Kapoor N, Paul TV. Trabecular bone score—An emerging tool in the management of osteoporosis.Indian J Endocr Metab 2020;24:237-243


How to cite this URL:
Rajan R, Cherian KE, Kapoor N, Paul TV. Trabecular bone score—An emerging tool in the management of osteoporosis. Indian J Endocr Metab [serial online] 2020 [cited 2020 Aug 4 ];24:237-243
Available from: http://www.ijem.in/article.asp?issn=2230-8210;year=2020;volume=24;issue=3;spage=237;epage=243;aulast=Rajan;type=0